Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 N Broadway St Bldg Rm10291
Baltimore, MD 21287Phone+1 443-287-6489Fax+1 410-614-9421
Education & Training
- Johns Hopkins UniversityFellowship, Medical Oncology, 2019
- University of Pittsburgh School of MedicineClass of 2012
Certifications & Licensure
- MD State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The Johns Hopkins Hope at Hopkins Clinic: supporting the comprehensive needs of individuals with metastatic breast cancer.Vered Stearns, Ruizhe Chen, Amanda L Blackford, Elizabeth Saylor, Jill Mull
Breast Cancer Research and Treatment. 2025-01-27 - 1 citationsDosage Optimization: A Regulatory Perspective for Developing Oncology Drugs.Atiqur Rahman, Mirat Shah, Stacy S Shord
Clinical Pharmacology and Therapeutics. 2024-09-01 - 1 citationsFDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations.Gautam U Mehta, Paz J Vellanki, Yi Ren, Anup K Amatya, Pallavi S Mishra-Kalyani
The Oncologist. 2024-08-05
Authored Content
- How to Get the Dose RightApril 2022
Press Mentions
- FDA’s Renewed Focus on Oncology Dosing Spooks Investors, but Companies Say They're ReadyJune 28th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: